● Ka maʻi hoʻouna i ke kāne

  • ʻO Herpes Simplex Virus Type 1

    ʻO Herpes Simplex Virus Type 1

    Hoʻohana ʻia kēia pahu no ka ʻike qualitative o Herpes Simplex Virus Type 1 (HSV1).

  • ʻO Chlamydia Trachomatis, Neisseria Gonorrhoeae a me Trichomonas vaginalis

    ʻO Chlamydia Trachomatis, Neisseria Gonorrhoeae a me Trichomonas vaginalis

    Kuhi ʻia ka pahu no ka ʻike in vitro qualitative o Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG)aʻO Trichomonal vaginitis (TV) i loko o ke kane urethral swab, wahine cervical swab, a me ka wahine vaginal swab samples, a hāʻawi i ke kōkua i ka ʻike a me ka mālama ʻana i nā maʻi me nā maʻi maʻi genitourinary.

  • ʻO Trichomonas Vaginalis Nucleic Acid

    ʻO Trichomonas Vaginalis Nucleic Acid

    Hoʻohana ʻia kēia kit no ka ʻike qualitative o Trichomonas vaginalis nucleic acid i loko o nā laʻana huna huna urogenital kanaka.

  • 14 Nā ʻano o ka maʻi maʻi maʻi maʻi Genitourinary

    14 Nā ʻano o ka maʻi maʻi maʻi maʻi Genitourinary

    Hoʻolālā ʻia ka pahu no ka ʻike in vitro qualitative o Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Mycoplasma hominis (Mh), Herpes simplex virus type 1 (HSV1), Ureaplasma urealyticum (UU), Herpes simplex virus type 2 ( HSV2), Ureaplasma parvum (UP), Mycoplasma genitalium (Mg), Candida albicans (CA), Gardnerella vaginalis (GV), Trichomonal vaginitis (TV), Group B streptococci (GBS), Haemophilus ducreyi (HD), a me Treponema pallidum ( TP) i loko o ke kane urethral swab, wahine cervical swab, a me ka wahine vaginal swab samples, a hāʻawi i ke kōkua i ka ʻike a me ka mālama ʻana i nā maʻi me nā maʻi maʻi genitourinary.

  • ʻEhiku Urogenital Pathogen

    ʻEhiku Urogenital Pathogen

    Hoʻohana ʻia kēia kit no ka ʻike qualitative o chlamydia trachomatis (CT), neisseria gonorrhoeae (NG) a me mycoplasma genitalium (MG), mycoplasma hominis (MH), herpes simplex virus type 2 (HSV2), ureaplasma parvum (UP) a me ureaplasma urealyticum (UU) nā ʻakika nucleic i loko o ka urethral swabs kāne a me ka wahine cervical swab samples in vitro, no ke kōkua ʻana i ka hōʻoia a me ka mālama ʻana i nā maʻi me nā maʻi maʻi genitourinary.

  • Mycoplasma Genitalium (Mg)

    Mycoplasma Genitalium (Mg)

    Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o Mycoplasma genitalium (Mg) nucleic acid i loko o ka ʻāpana mimi kāne a me nā mea huna huna wahine.

  • Ureaplasma Urealycum Nucleic Acid

    Ureaplasma Urealycum Nucleic Acid

    He kūpono kēia kit no ka ʻike qualitative o Ureaplasma urealyticum (UU) i loko o ka ʻāpana mimi kāne a me nā ʻāpana huna huna wahine i loko o ka vitro.

  • Mycoplasma Hominis Nucleic Acid

    Mycoplasma Hominis Nucleic Acid

    He mea kūpono kēia pahu no ka ʻike qualitative o Mycoplasma hominis (MH) i loko o ka ʻāpana mimi kāne a me nā ʻāpana huna huna wahine.

  • Herpes Simplex Virus Type 1/2,(HSV1/2) Nucleic Acid

    Herpes Simplex Virus Type 1/2,(HSV1/2) Nucleic Acid

    Hoʻohana ʻia kēia pahu no ka ʻike in vitro qualitative o Herpes Simplex Virus Type 1 (HSV1) a me Herpes Simplex Virus Type 2 (HSV2) e kōkua i ka hoʻomaʻamaʻa a mālama ʻana i nā poʻe maʻi i manaʻo ʻia he maʻi HSV.

  • HIV Ka nui

    HIV Ka nui

    Hoʻohana ʻia ʻo HIV Quantitative Detection Kit (Fluorescence PCR) (ma hope aʻe nei ʻo ka kit) no ka ʻike nui ʻana o ka maʻi maʻi immunodeficiency kanaka (HIV) RNA i loko o ka serum kanaka a i ʻole nā ​​laʻana plasma.

  • Neisseria Gonorrhoeae Nucleic Acid

    Neisseria Gonorrhoeae Nucleic Acid

    Hoʻolālā ʻia kēia pahu no ka ʻike in vitro o Neisseria Gonorrhoeae(NG) nucleic acid i loko o ka mimi kāne, ka urethral swab kāne, ka wahine cervical swab samples.

  • ʻO ka Cytomegalovirus kanaka (HCMV) Nucleic Acid

    ʻO ka Cytomegalovirus kanaka (HCMV) Nucleic Acid

    Hoʻohana ʻia kēia pahu no ka hoʻoholo ʻana i ka qualitative o nā waikawa nucleic i nā laʻana me ka serum a i ʻole ka plasma mai nā mea maʻi i manaʻo ʻia he maʻi HCMV, i mea e kōkua ai i ka hōʻoia ʻana o ka maʻi HCMV.

12Aʻe >>> ʻAoʻao 1 / 2